Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics

Started by MikeLigalig.com, January 06, 2017, 11:38:46 AM

Previous topic - Next topic
Print
Go Down Pages1
User actions

MikeLigalig.com

January 06, 2017, 11:38:46 AM
Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics

SAN FRANCISCO, Jan. 4, 2017 /PRNewswire/ -- Pionyr Immunotherapeutics Inc. (formerly Precision Immune Inc.), a company harnessing the body's antitumor immunity by fine-tuning the tumor microenvironment, announced the closing of an $8 million Series A-1 investment round. The latest...

Source: Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics
For God so loved the world, that he gave his only Son (Jesus Christ), that whoever believes in him should not perish but have eternal life. For God did not send his Son into the world to condemn the world, but in order that the world might be saved through him. Whoever believes in him is not condemned, but whoever does not believe is condemned already, because he has not believed in the name of the only Son of God. - John 3:16-18

● ● ● ●
MOST AFFORDABLE health insurance HMO in the Philippines. Learn more at https://kwik.insure/at/mligalig
Print
Go Up Pages1
User actions